Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8938198 | British Journal of Anaesthesia | 2008 | 10 Pages |
Abstract
In human catecholamine-dependent septic shock, terlipressin (with and without concomitant dobutamine infusion) increases MAP and markedly reduces norepinephrine requirements. Although no adverse events were noticed in the present study, potential benefits of increasing Svo2 after terlipressin bolus infusion need to be weighted against the risk of cardiovascular complications resulting from high-dose dobutamine.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
A. Morelli, C. Ertmer, M. Lange, M. Dünser, S. Rehberg, H. Van Aken, P. Pietropaoli, M. Westphal,